3-triazolyl methyl-1,3,5-triazine-2,4-dione compounds and preparation method and application thereof

US11612603B1 · kind B1 · utility

Assignee

• SHAANXI PANLONG PHARMACEUTICAL CO., LTD. · CN

Inventors

• Chengyuan Liang · Xi'an, CN
• Liang Xin · Xi'an, CN
• Lei Tian · Batou, CN
• Jingyi Li · Xi'an, CN
• Xiaolin Xie · Xi'an, CN
• Dezhu Zhang · Xi'an, CN
• Kangxiong Wu · Xi'an, CN
• Shaojun Zhang · Xi'an, CN
• Xiuding Yang · Xi'an, CN
• Sundian Liu · Xi'an, CN
• Yuting Liu · Tangxia, CN
• Zhao Ma · Xi'an, CN
• Xuhua Zhou · Xi'an, CN

Key dates

• Filing date: Jul 17, 2022
• Grant date: Mar 28, 2023
• Expiry date: Jul 17, 2042

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P31/14
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Disclosed is a compound of formula I, a pharmaceutically acceptable salt, or a tautomer thereof. formula I. R1, R2, R3 and R4 are independently selected from the group consisting of hydrogen, methyl group, tert-butyl group, methoxy group, difluoromethyl, trifluoromethyl, trifluoromethoxy, nitro, halogen, phenyl and aromatic heterocyclic; R5 is a hydrogen or halogen; and R6 is hydrogen, C1-4 alkane or C1-4 cycloalkane.